Concepedia

Claude Denham

CD

Statistics

Publications

8

Citations

4.2K

H-Index

8

Active since

1996

Affiliations

Texas Oncology(Current)

Heidelberg University

University Hospital Heidelberg

Baylor University Medical Center

Allgemeines Krankenhaus Celle

Claude Denham is an author at Texas Oncology specializing in oncology, medicine, and chemotherapy.

Publications per year

1996–2023

8

Publications

8

Phase III Study of Pemetrexed in Combination With Cisplatin Versus Cisplatin Alone in Patients With Malignant Pleural Mesothelioma

Nicholas J. Vogelzang, James J. Rusthoven, James T. Symanowski et al. · Journal of Clinical Oncology · 2003 · 3.1K citations

, , +13

Phase III Trial of Gemcitabine Plus Cisplatin Versus Cisplatin Alone in Patients With Locally Advanced or Metastatic Non–Small-Cell Lung Cancer

Alan B. Sandler, John Nemunaitis, Claude Denham et al. · Journal of Clinical Oncology · 2000 · 719 citations

, , +14

Phase III Study of Pemetrexed in Combination With Cisplatin Versus Cisplatin Alone in Patients With Malignant Pleural Mesothelioma

Nicholas J. Vogelzang, James J. Rusthoven, James T. Symanowski et al. · Journal of Clinical Oncology · 2023 · 253 citations

, , +13

Management of Central Giant Cell Granuloma With Subcutaneous Denosumab Therapy

Aparna Naidu, Michael P. Malmquist, Claude Denham et al. · Journal of Oral and Maxillofacial Surgery · 2014 · 72 citations

, , +7

Randomized double-blind prospective trial to evaluate the effects of sargramostim versus placebo in a moderate-dose fluorouracil, doxorubicin, and cyclophosphamide adjuvant chemotherapy program for stage II and III breast cancer.

Sarah E. Jones, M W Schottstaedt, Lewis A. Duncan et al. · Journal of Clinical Oncology · 1996 · 52 citations

, , +16

1–5 of 8